Paroxetine controlled release tablet

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Depressive Disorder

Phase 1

Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects

CompletedNCT00406003

GlaxoSmithKlineDepressive Disorder

Start: 2006-03-24End: 2006-04-26Updated: 2017-09-29

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

CompletedNCT00406432

GlaxoSmithKlineDepressive Disorder

Start: 2006-05-09End: 2006-06-02Updated: 2017-09-29